Anteneh Belayneh Melese is a dynamic pharmaceutical researcher and Lecturer of Pharmaceutics at Debre Markos University, Ethiopia, whose scholarly work spans pharmacokinetics, drug–food interactions, pediatric pharmaceutics, public health, and evidence-based medicine. His research has significantly advanced understanding of antidiabetic flavonoids through computational approaches, particularly molecular docking and density functional theory, revealing their pharmacokinetic behavior and drug-likeness properties. He has also contributed a widely referenced review on the influence of coffee consumption on drug pharmacokinetics, synthesizing evidence on how caffeine and related compounds alter drug metabolism and absorption, which has become a critical resource for clinicians and pharmacists. His investigations into the safety, stability, and biopharmaceutical challenges of excipients in pediatric formulations highlight major gaps in off-label pediatric drug compounding, emphasizing toxicity risks, formulation instability, and regulatory limitations. Anteneh’s impactful commentary on the off-label use of chloroquine and hydroxychloroquine for COVID-19 treatment in Africa critically examined their clinical risks and helped guide rational therapeutic decisions during the pandemic. His contributions also extend to ethnomedicine and public health, including systematic reviews on medicinal animals, traditional remedies for hemorrhoids, and antimicrobial resistance patterns among pediatric patients, reflecting a strong commitment to integrating indigenous knowledge with modern healthcare. Additionally, his research on medication non-adherence among diabetic patients and improper metered-dose inhaler techniques underscores his focus on patient-centered pharmaceutical care. Anteneh has further advanced pharmaceutics through formulation work, including optimizing monolithic fixed-dose combinations and orodispersible tablets for improved therapeutic outcomes. With over a decade of scientific engagement, more than 500 citations, and collaborations with international chemists, pharmacologists, and biochemists, his research portfolio demonstrates strong interdisciplinary impact. His body of work collectively strengthens pharmaceutical sciences, enhances medication safety, and supports the development of accessible, evidence-based healthcare solutions in Ethiopia and beyond.